International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 4 : 522-527
Research Article
Role of Diagnostic Hysterolaproscopy in Infertility Management at Tertiary Care Hospital in South India
 ,
 ,
Received
June 5, 2026
Accepted
June 25, 2026
Published
July 8, 2026
Abstract

Background: Infertility affects approximately 10–15% of reproductive-age couples, with female factors contributing significantly. Diagnostic hysterolaparoscopy (DHL) is considered the gold standard for evaluating tubal patency and detecting pelvic and uterine pathologies that may not be identified by routine clinical examination or ultrasonography.

Objective: To evaluate the role of diagnostic hysterolaparoscopy in the assessment and management of female infertility in a tertiary care hospital.

Methods: A retrospective observational study was conducted among 82 women aged 20–40 years who underwent diagnostic hysterolaparoscopy for infertility evaluation between May 2020 and February 2023 at Dr. B. R. Ambedkar Medical College and Hospital. Data were retrieved from medical records and analyzed using SPSS software. Clinical characteristics and hysteroscopic and laparoscopic findings were assessed.

Results: Primary infertility was observed in 73.2% of women, while 26.8% had secondary infertility. The mean age was 27.2 ± 2.6 years, and most patients (56.1%) belonged to the 25–29-year age group. The majority (87.8%) had infertility of ≤5 years' duration. Overweight and obesity were present in 57.3% and 14.6% of patients, respectively. Laparoscopic abnormalities were more frequent than hysteroscopic abnormalities, with tuboperitoneal pathology being the predominant finding. Bilateral peritubal adhesions and hydrosalpinx were the most common abnormalities. The most common hysteroscopic finding was an endometrial polyp. Simultaneous therapeutic procedures such as adhesiolysis and ablation of endometriotic lesions were performed whenever indicated.

Conclusion: Diagnostic hysterolaparoscopy is a valuable minimally invasive procedure for the comprehensive evaluation of female infertility. It facilitates the diagnosis of occult pelvic and intrauterine pathologies while allowing simultaneous therapeutic intervention, thereby improving clinical management of infertile women, particularly in resource-limited settings.

Keywords
INTRODUCTION

WHO Definition of Infertility - “A disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.”

 

The prevalence of infertility is about 10%–15% of reproductive age couples.

Among the causes of infertility female factor (40%–55%) remains the foremost reason followed by male factor (30%–40%), combined factor (10%), whereas in 10% cases etiology remains unexplained.

 

Among female factor infertility, the most common cause is tuboperitoneal pathology accounting for 30%–35% cases followed by ovulatory dysfunction (20%–30% cases) and uterine pathology (15% cases).

 

Diagnostic hysterolaparoscopy (DHL) has emerged as the essential tool for the evaluation of female infertility and is the gold standard investigation for tubal patency.

 

The importance of DHL lies in the fact that it gives a detailed, direct visualization and analysis of the uterine cavity, endometrium, tubal morphology and patency, uterine, ovarian, and adnexal pathology.

 

These pathology findings are often missed in routine clinical examination and ultrasound scan. This study was undertaken to find out role of DHL in evaluation of female infertility.

 

OBJECTIVE

The objective of this study is to analyze the role of diagnostic hysterolaparoscopy (DHL) for evaluation of infertility and management in a tertiary care hospital.

 

STUDYDESIGN- Retrospective observational Study

 

STUDY PERIOD- MAY 2020 - FEB 2023

 

SAMPLESIZE-84

 

STUDYPLACE-DR B R Ambedkar medical college and Hospital

 

METHODOFCOLLECTION-data collected from bmedical record department

 

INCLUSIONCRITERIA

All patients between 20-40 years presented within fertility(primary and secondary) who has undergone DHL as a part of management.

 

EXCLUSIONCRITERIA

When cause of infertility is known either by USG, HSG, Hormone analysis.

 

STATISTICALANALYSIS

Statistical analysis was performed using SPSS (IBM Corp .SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.) software version 16. Student’st-test and Chi-square test were performed for comparison of continuous variable and proportions, respectively.

 

RESULTS

A total number of 84 patients underwent DHL out of which 60 (73.2%) suffered from primary infertility and 22(26.8%) suffered from secondary infertility.

 

Type

Number

Percentage

Primary

60

73.2

Secondary

22

26.8

Total

82

100.0

 

AGE

Majority of the patients belong to age group 25 to 29 years. The mean age of patients with infertility was 27.2 ± 2.6 years

 

Age

Number

Percentage

20to24Years

15

18.3

25to29Years

46

56.1

30to34Years

17

20.7

35to39Years

04

04.9

Total

82

100.0

 

DURATION

Majority of the cases of infertility belong to the duration of <5 yrs. The mean durationof infertility in primary and secondary infertility was 4.9 ±2.2 years and 4.8 ± 2.7 years, respectively. However it is statistically insignificant.

 

Duration

Number

Percentage

<=5 Years

72

87.8

>5 Years

10

12.2

Total

82

100.0

 

BMI

Among84 cases, 23 cases(28.1%) belongto normalBMI,and47(57.3%) belong to overweight category, and 12 cases (14.6%) belong to obese category. Statistically Significant association with BMI is seen.

 

BMI

Number

Percentage

18.5to 24.9(Normal)

23

28.1

25to 29.9(Overweight)

47

57.3

30andMore(Obese)

12

14.6

Total

82

100.0

 

PRIOR TREATMENT

Around43 cases(52.4%) prior treatment with ovulation induction and IUI. And majority of cases have been taken treatment for 3 years which was failed.

 

Treatment

Number

Percentage

Yes

43

52.4

No

39

47.6

Total

82

100.0

Priortreatment

Primaryinfertility

Secondary infertility

OI

22

7

IUI

9

11

 

ABNORMALFINDINGS

In both primary and secondary infertility patients, laparoscopic abnormalities (37.6% and 49.2%) were more common thanthe hysteroscopic ones (7.3% and 14.2%). In both groups tubal factors was predominant, of which bilateral peritubal adhesions and hydrosalphinx found to be the most common cause.

 

 

Tubes

Number

Percentage

 

Patent

65

79.2

 

Adhesion

Number

Percenatge

 

Hydrosalphinx(b/l)

6

7.3

 

NIL

50

61.0

U/ltubepatent

2

2.4

 

Adhesions present at right fimbrial end

1

1.2

 

Present

29

35.4

 

Adhesions +in pod and fimbrialendofrighttube

1

1.2

B/lblockage

1

1.2

 

Flimsyadhesions

1

1.2

 

Normal,b/lsp+

1

1.2

 

Dense

1

1.2

Righthydrosalphinx,u/l

patent

1

1.2

 

Noted

1

1.2

Righthydrosalphinx,u/lsp+

1

1.2

 

Rightishthmicnodosa,tubes

patent

1

1.2

 

Total

82

100.0

 

 

Submucosalfibroid

1

1.2

 

U/lblockage

1

1.2

 

Total

82

100.0

 

 

Around2%ofpatientsendometrioticspotswasseeninlaparoscopyand ablation of them was done in the same sitting. The most common abnormality in hysteroscopy was uterine polyp.

 

Hysteroscopy

Number

Percentage

Normal

66

80.5

Polyp

6

7.3

Endometritis

2

2.4

Submucosalfibroid

2

2.4

Adhesions

1

1.2

Fibroid

1

1.2

Flimsyadhesions

1

1.2

Septateuterus

1

1.2

Subseptateuterus

1

1.2

Unicornuateutrerus

1

1.2

Total

82

100.0

 

CONCLUSION

From this study it is noted that primary infertility is more common than secondary infertility, in mean age group of 27 yrs. Incidence increases with rise in BMI. Peritubal adhesions due to PID was the most common cause and simultaneous a dhesiolysis was done.

 

DHL is helpful in identifying undetected treatable causes of infertility. It also gives advantage of providing simultaneous correction at the same instance and of course, it is a minimal invasive procedure.

 

Reversible causes of infertility such as a dnexaladhesions, tubal blockade, uterine synechiae, etc., can easily be diagnosed and treated by hysterolaparoscopy.

 

However, in the era of advanced ultrasound, in developing countries diagnostic hysterolaparosccopy may still offer some hope to the in fertile couple.

 

REFERENCES

  1. Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking:Potentialneedanddemandforinfertilitymedicalcare.2007;22:1506– 12.
  2. RamanandSJ,GhonganeBB,RamanandJB,PatwardhanMH,GhanghasRR,JainSS.Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab. 2013 Jan;17(1):138-45. doi: 10.4103/2230-8210.107858. PMID: 23776867; PMCID: PMC3659881.
  3. Insulinresistanceandthepolycysticovarysyndrome:Mechanismandimplicationsfor pathogenesis. Endocr Rev. 1997;18:774–800. [PubMed] [Google Scholar]
  4. RotterdamESHRE/ASRM-SponsoredPCOSconsensusworkshopgroup.Revised2003consensuson
  5. diagnosticcriteriaandlong-termhealthrisksrelatedtopolycysticovarysyndrome.Fertil
  6. Steril.2004;81:19–25.[PubMed][GoogleScholar]
  7. NidhiR,PadmalataV,NagarathnaR,AmritanshuR.Prevalenceofpolycysticovariansyndromein Indian adolescents. J Pediatr Adolesc Gynecol. 2011;24:223–7. [PubMed] [Google Scholar]
  8. WilliamsonK,GunnAJ,JohnsonN,MilsomSR.Theimpactofethnicityonthepresentationo polycysticovariansyndrome.AustNZJObstetGynaecol.2001;41:202–6.[PubMed][GoogleScholar]
  9. NormanRJ,MahabeerS,MastersS.Ethnicdifferencesininsulinandglucoseresponsetoglucose between white and Indian women with polycystic ovary syndrome. Fertil Steril. 1995;63:58 62.[PubMed][GoogleScholar]
Recommended Articles
Research Article Open Access
A Comparative Study Of 2% Intravenous Lignocaine Vs 50% Intravenous Magnesium Sulphate in Attenuation of Hemodynamic Stress Response to Endotracheal Intubation
2026, Volume-7, Issue 4 : 573-581
Research Article Open Access
Comparing Ease of Intubation in Obese and Lean Patients Using the Intubation Difficulty Scale: A Prospective Observational Study
2026, Volume-7, Issue 4 : 548-555
Research Article Open Access
Clinical and Radiological Predictors of Difficult Laryngoscopy and Intubation: A Prospective Observational Study
2025, Volume-6, Issue-4 : 1696-1701
Case Series Open Access
Black Hairy Tongue: A Rare Adverse Event in Patients Receiving BPaLM Regimen for MDR-TB: A Case Series
2026, Volume-7, Issue 4 : 537-540
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 4
Citations
8 Views
5 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved